Gilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
| Avoid common pitfalls in EU orphan drug market access—learn how local expertise can help navigate pricing, reimbursement, ...
As the demand for high-quality, GMP-compliance software continues to grow across global markets, this new Spanish-language website enables more manufacturers to streamline operations, enhance ...
We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Cytokinetics, Incorporated (NASDAQ: CYTK) stands ...
With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through ...
Apellis (APLS) and Sobi announced the European Medicines Agency has validated an indication extension application for Aspaveli for the ...
One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...
The automaker’s sales were down in the three largest European markets for electric cars in January. In Germany, home to Tesla’s only factory in Europe, only 1,277 new Tesla vehicles were ...
Biden's remarks as he departed Joint Base Andrews 01:09 Former President Joe Biden has signed with the powerhouse talent agency CAA, joining its star-studded ranks of Hollywood actors and sports ...